Nanjing Hicin Pharmaceutical Co., Ltd. (SHE:300584)
China
· Delayed Price · Currency is CNY 42.27
-1.05 (-2.42%)
Apr 30, 2026, 3:04 PM CST
SHE:300584 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 5,198 | 6,026 | 2,419 | 2,794 | 3,864 | 2,400 | Upgrade
|
| Market Cap Growth | 109.28% | 149.11% | -13.40% | -27.70% | 61.00% | -2.53% | Upgrade
|
| Enterprise Value | 5,469 | 6,278 | 2,671 | 2,943 | 3,897 | 2,479 | Upgrade
|
| Last Close Price | 43.32 | 50.22 | 20.10 | 23.14 | 32.00 | 19.73 | Upgrade
|
| PE Ratio | 117.11 | 143.29 | 60.15 | 76.93 | 119.08 | 8.40 | Upgrade
|
| Forward PE | - | 26.20 | 26.20 | 26.20 | 26.20 | 26.20 | Upgrade
|
| PS Ratio | 7.55 | 8.98 | 4.80 | 5.40 | 7.34 | 4.15 | Upgrade
|
| PB Ratio | 4.66 | 5.48 | 2.33 | 2.83 | 4.07 | 2.53 | Upgrade
|
| P/TBV Ratio | 5.43 | 6.45 | 2.74 | 3.25 | 4.73 | 2.90 | Upgrade
|
| P/FCF Ratio | - | 390.08 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 114.14 | 77.17 | 40.35 | 116.73 | - | 40.04 | Upgrade
|
| EV/Sales Ratio | 7.94 | 9.36 | 5.30 | 5.68 | 7.40 | 4.29 | Upgrade
|
| EV/EBITDA Ratio | 35.09 | 40.84 | 25.38 | 29.58 | 47.13 | 37.32 | Upgrade
|
| EV/EBIT Ratio | 62.73 | 69.96 | 50.98 | 64.05 | 112.54 | 84.27 | Upgrade
|
| EV/FCF Ratio | -1788.69 | 406.33 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.27 | 0.26 | 0.30 | 0.27 | 0.19 | 0.19 | Upgrade
|
| Debt / EBITDA Ratio | 1.88 | 1.84 | 2.99 | 2.72 | 2.15 | 2.71 | Upgrade
|
| Debt / FCF Ratio | - | 18.56 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.20 | 0.20 | 0.26 | 0.23 | 0.09 | 0.07 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.45 | 1.44 | 2.56 | 2.25 | 1.00 | 0.97 | Upgrade
|
| Net Debt / FCF Ratio | -73.58 | 14.28 | -14.96 | -1.29 | -0.37 | -1.88 | Upgrade
|
| Asset Turnover | 0.46 | 0.45 | 0.35 | 0.38 | 0.41 | 0.52 | Upgrade
|
| Inventory Turnover | 1.53 | 1.45 | 1.11 | 1.39 | 2.24 | 1.74 | Upgrade
|
| Quick Ratio | 0.79 | 0.78 | 0.74 | 0.64 | 0.96 | 0.79 | Upgrade
|
| Current Ratio | 1.07 | 1.04 | 1.07 | 0.94 | 1.19 | 1.00 | Upgrade
|
| Return on Equity (ROE) | 3.88% | 3.81% | 3.96% | 3.75% | 3.38% | 35.00% | Upgrade
|
| Return on Assets (ROA) | 3.68% | 3.74% | 2.28% | 2.13% | 1.67% | 1.67% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.11% | 5.88% | 4.07% | 3.94% | 3.38% | 2.90% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.60% | 7.70% | 4.60% | 4.60% | 3.50% | 2.90% | Upgrade
|
| Earnings Yield | 0.85% | 0.70% | 1.66% | 1.30% | 0.84% | 11.91% | Upgrade
|
| FCF Yield | -0.06% | 0.26% | -0.74% | -6.20% | -5.82% | -1.44% | Upgrade
|
| Dividend Yield | 0.24% | - | 0.50% | 0.22% | - | 1.27% | Upgrade
|
| Payout Ratio | 43.53% | 46.38% | 34.44% | 17.80% | 109.40% | 7.70% | Upgrade
|
| Buyback Yield / Dilution | 0.02% | 0.02% | -0.01% | -0.01% | -0.00% | -0.01% | Upgrade
|
| Total Shareholder Return | 0.26% | 0.02% | 0.49% | 0.21% | -0.00% | 1.26% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.